{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:58:40Z","timestamp":1761217120763,"version":"3.44.0"},"reference-count":43,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Path"],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1136\/mp.50.5.247","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:45:53Z","timestamp":1181349953000},"page":"247-253","source":"Crossref","is-referenced-by-count":19,"title":["Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas."],"prefix":"10.1136","volume":"50","author":[{"given":"J A","family":"Holden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M P","family":"Rahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C J","family":"Jolles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S V","family":"Vorobyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I B","family":"Bronstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1997,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","article-title":"DNA topoisomerases","volume":"65","author":"Wang, J.C.","year":"1996","unstructured":"Wang JC. DNA topoisomerases. Annu Rev Biochem 1996;65:635-92.","journal-title":"Annu Rev Biochem"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0092-8674(86)90461-7","article-title":"Topoisomerase I interacts with transcribed regions in drosophila cells","volume":"44","author":"Gilmour, D.S.; Pflugfelder, G.; Wang, J.C.; Lis, J.T.","year":"1986","unstructured":"Gilmour DS, Pflugfelder G, Wang JC, Lis JT. Topoisomerase I interacts with transcribed regions in drosophila cells. Cell 1986;44:401-7.","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1128\/MCB.7.1.141","article-title":"Localization of specific topoisomerase I interactions within the transcribed region of active heat shock genes by using the inhibitor camptothecin","volume":"7","author":"Elgin, S.C.R.; Gilmour, D.S.","year":"1987","unstructured":"Elgin SCR, Gilmour DS. Localization of specific topoisomerase I interactions within the transcribed region of active heat shock genes by using the inhibitor camptothecin. Mol Cell Biol 1987;7:141-8.","journal-title":"Mol Cell Biol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0092-8674(87)90177-2","article-title":"Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene","volume":"50","author":"Stewart, A.F.; Schutz, G.","year":"1987","unstructured":"Stewart AF, Schutz G. Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene. Cell 1987;50:1109-17.","journal-title":"Cell"},{"key":"ref_5","first-page":"11508","article-title":"Identification of human DNA topoisomerase I as a cofactor for activatordependent transcription by","volume-title":"RNA polymerase II. Proc Natl Acad Sci USA","volume":"90","author":"Kretzschmar, M.; Meisterernst, M.; Roeder, R.G.","year":"1993","unstructured":"Kretzschmar M, Meisterernst M, Roeder RG. Identification of human DNA topoisomerase I as a cofactor for activatordependent transcription by RNA polymerase II. Proc Natl Acad Sci USA 1993;90:11508-12."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/365227a0","article-title":"DNA topoisomerase I is involved in both repression and activation of transcription","volume":"365","author":"Merino, A.; Madden, K.R.; Lane, W.S.; Champoux, J.J.; Reinberg, D.","year":"1993","unstructured":"Merino A, Madden KR, Lane WS, Champoux JJ, Reinberg D. DNA topoisomerase I is involved in both repression and activation of transcription. Nature 1993;365:227-32.","journal-title":"Nature"},{"key":"ref_7","first-page":"755","article-title":"Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin","volume":"34","author":"Eng, W.; Faucette, L.; Johnson, R.K.; Sternglanz, R.","year":"1989","unstructured":"Eng W, Faucette L, Johnson RK, Sternglanz R. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol Pharm 1989;34:755-60.","journal-title":"Mol Pharm"},{"key":"ref_8","first-page":"6318","article-title":"Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumour drug camptothecin","volume":"49","author":"Bjornsti, M.A.; Benedetti, P.; Viglianti, G.A.; Wang, J.C.","year":"1989","unstructured":"Bjornsti MA, Benedetti P, Viglianti GA, Wang JC. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumour drug camptothecin. CancerRes 1989;49:6318-23.","journal-title":"CancerRes"},{"key":"ref_9","first-page":"625","article-title":"Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix. 3JClin Oncol","volume":"15","author":"Verschraegen, C.F.; Levy, T.; Kudelka, A.P.; Llerena, E.; Ende, K.; Freedman, R.S.","year":"1997","unstructured":"Verschraegen CF, Levy T, Kudelka AP, Llerena E, Ende K, Freedman RS, et al. Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix. 3JClin Oncol 1997;15:625-31."},{"key":"ref_10","first-page":"709","article-title":"Irinotecan is an active agent in untreated patients with metastatic colorectal cancer","volume":"14","author":"Conti, J.A.; Kemeny, N.E.; Saltz, L.B.; Huang, Y.; Tong, W.P.; Chao, T.","year":"1996","unstructured":"Conti JA, Kemeny NE, Saltz LB, Huang Y, Tong WP, Chao T, et al. Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. _7 Clin Oncol 1996;14: 709-15."},{"key":"ref_11","first-page":"3056","article-title":"-an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study","volume":"14","author":"Creemers, G.J.; Bolis, G.; Scarfone, G.; Lacave, A.J.; Guastalla, J.P.; Despax, R.","year":"1996","unstructured":"Creemers GJ, Bolis G, Scarfone G, Lacave AJ, Guastalla JP, Despax R, et al. Topotecan, -an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study. _7 Clin Oncol 1996;14:3056-61."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13373","DOI":"10.1016\/S0021-9258(18)80002-3","article-title":"Mapping of the active site tyrosine of eukaryotic DNA topoisomerase","volume":"264","author":"Eng, W.; Pandit, S.D.; Sternglanz, R.","year":"1989","unstructured":"Eng W, Pandit SD, Sternglanz R. Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I. I Biol Chem 1989;264:13373-6.","journal-title":"I. I Biol Chem"},{"key":"ref_13","first-page":"1339","article-title":"Mutation at the catalytic site of topoisomerase I in CEM\/C2, a human leukemia cell line resistant to camptothecin","volume":"55","author":"Fujimori, A.; Harker, W.G.; Kohlhagen, G.; Hoki, Y.; Pommier, Y.","year":"1995","unstructured":"Fujimori A, Harker WG, Kohlhagen G, Hoki Y, Pommier Y. Mutation at the catalytic site of topoisomerase I in CEM\/C2, a human leukemia cell line resistant to camptothecin. Cancer Res 1995;55:1339-46.","journal-title":"Cancer Res"},{"key":"ref_14","first-page":"14873","article-title":"Campthothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I..7 Biol","volume":"260","author":"Hsiang, Y.; Hertzberg, R.; Hecht, S.; Liu, L.F.","year":"1985","unstructured":"Hsiang Y, Hertzberg R, Hecht S, Liu LF. Campthothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I..7 Biol Chem 1985;260:14873-8.","journal-title":"Chem"},{"key":"ref_15","first-page":"5077","article-title":"Arrest of replication forks by drug-stabilised topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin","volume":"49","author":"Hsiang, Y.; Lihou, M.G.; Liu, L.F.","year":"1989","unstructured":"Hsiang Y, Lihou MG, Liu LF. Arrest of replication forks by drug-stabilised topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 1989;49:5077-5082.","journal-title":"Cancer Res"},{"key":"ref_16","first-page":"1095","article-title":"Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA","volume":"50","author":"Nitiss, J.L.; Wang, J.C.","year":"1996","unstructured":"Nitiss JL, Wang JC. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA. Mol Pharmacol 1996;50:1095-102.","journal-title":"Mol Pharmacol"},{"key":"ref_17","first-page":"525","article-title":"Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin","volume":"52","author":"Madden, K.R.; Champoux, J.J.","year":"1992","unstructured":"Madden KR, Champoux JJ. Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin. Cancer Res 1992;52:525-32.","journal-title":"Cancer Res"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/nar\/19.1.69","article-title":"Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites","volume":"19","author":"true","year":"1991","unstructured":"Tamura H, Kohchi C, Yamada R, Ikeda T, Koiwai 0, Petterson E, et al. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites. Nucleic Acids Res 1991;19: 69-75.","journal-title":"Nucleic Acids Res"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25463","DOI":"10.1016\/S0021-9258(19)74414-7","article-title":"Cloning of chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation reponsible for camptothecin resistance","volume":"268","author":"Tanizawa, A.; Bertrand, R.; Kohlhagen, G.; Tabuchi, A.; Jenkins, J.; Pommier, Y.","year":"1993","unstructured":"Tanizawa A, Bertrand R, Kohlhagen G, Tabuchi A, Jenkins J, Pommier Y. Cloning of chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation reponsible for camptothecin resistance. _7 Biol Chem 1993;268:25463-8.","journal-title":"_7 Biol Chem"},{"key":"ref_20","first-page":"4343","article-title":"Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine","volume":"53","author":"Benedetti, P.; Fiorani, P.; Capuani, L.; Wang, J.C.","year":"1993","unstructured":"Benedetti P, Fiorani P, Capuani L, Wang JC. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Cancer Res 1993; 53:4343-8.","journal-title":"Cancer Res"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/S0021-9258(17)41964-8","article-title":"Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitrocamptothecin","volume":"269","author":"Rubin, E.; Pantazis, P.; Bharti, A.; Toppmeyer, D.; Biovanella, B.; Kufe, D.","year":"1994","unstructured":"Rubin E, Pantazis P, Bharti A, Toppmeyer D, Biovanella B, Kufe D. Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitrocamptothecin. JBiol Chem 1994;269:2433-9.","journal-title":"JBiol Chem"},{"key":"ref_22","first-page":"539","article-title":"Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumours: demonstration of tumour-type specificity and implications for cancer chemotherapy","volume":"54","author":"Husain, I.; Mohler, J.L.; Seigler, H.F.; Besterman, J.M.","year":"1994","unstructured":"Husain I, Mohler JL, Seigler HF, Besterman JM. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumours: demonstration of tumour-type specificity and implications for cancer chemotherapy. CancerRes 1994;54:539-46.","journal-title":"CancerRes"},{"key":"ref_23","first-page":"607","article-title":"Topoisomerase I and II activity in human breast, cervix, lung, and colon cancer","volume":"59","author":"McLeod, H.L.; Douglas, F.; Oates, M.; Symonds, R.P.; Prakash, D.; van der Zee, A.G.J.","year":"1994","unstructured":"McLeod HL, Douglas F, Oates M, Symonds RP, Prakash D, van der Zee AGJ, et al. Topoisomerase I and II activity in human breast, cervix, lung, and colon cancer. Int 7 Cancer 1994;59:607-11."},{"key":"ref_24","first-page":"17","article-title":"Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies","volume":"8","author":"Bronstein, I.B.; Vorobyev, S.; Timofeev, A.; Jolles, C.J.; Alder, S.L.; Holden, J.A.","year":"1996","unstructured":"Bronstein IB, Vorobyev S, Timofeev A, Jolles CJ, Alder SL, Holden JA. Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies. Oncol Res 1996;8:17-25.","journal-title":"Oncol Res"},{"key":"ref_25","first-page":"45","article-title":"Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas","volume":"104","author":"Holden, J.A.; Perkins, S.L.; Snow, G.W.; Kjeldsberg, C.R.","year":"1995","unstructured":"Holden JA, Perkins SL, Snow GW, Kjeldsberg CR. Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas. An _7 Clitn Pathol 1995;104: 45-59."},{"key":"ref_26","first-page":"1229","article-title":"DNA topoisomerase II-alpha: immunohistochemical staining for enzyme protein in tumours of ovarian origin","volume":"10","author":"Martinchick, J.C.; Rahn, M.P.; Jolles, C.J.; Holden, J.A.","year":"1997","unstructured":"Martinchick JC, Rahn MP, Jolles CJ, Holden JA. DNA topoisomerase II-alpha: immunohistochemical staining for enzyme protein in tumours of ovarian origin. Iit _7 Oncol 1997;10:1229-34."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/nar\/11.4.1059","article-title":"DNA topoisomerases from rat liver: physiological variations","volume":"11","author":"Duguet, M.; Lavenot, C.; Harper, F.; Mirambeau, G.; De Recondo, A.M.","year":"1983","unstructured":"Duguet M, Lavenot C, Harper F, Mirambeau G, De Recondo AM. DNA topoisomerases from rat liver: physiological variations. Nucleic Acids Res 1983;11:1059-74.","journal-title":"Nucleic Acids Res"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1073\/pnas.85.4.1086","article-title":"Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle","volume":"85","author":"Heck, M.M.S.; Hittelman, W.N.; Earnshaw, W.C.","year":"1988","unstructured":"Heck MMS, Hittelman WN, Earnshaw WC. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 1988;85: 1086-90.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_29","first-page":"134","article-title":"Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy","volume":"19","author":"Baker, S.D.; Wadkins, R.M.; Stewart, C.F.; Beck, W.T.; Danks, M.K.","year":"1995","unstructured":"Baker SD, Wadkins RM, Stewart CF, Beck WT, Danks MK. Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy. Cytonsetry 1995;19: 134-45.","journal-title":"Cytonsetry"},{"key":"ref_30","first-page":"3467","article-title":"Purification of DNA topoisomerase I from the spleen of a patient with non-Hodgkin's lymphoma","volume":"16","author":"Florell, SR, Martinchick; JF, Holden; J.A.","year":"1996","unstructured":"Florell SR, Martinchick JF, Holden JA. Purification of DNA topoisomerase I from the spleen of a patient with non-Hodgkin's lymphoma. Anticanicer Res 1996;16:3467-73.","journal-title":"Anticanicer Res"},{"key":"ref_31","first-page":"863","article-title":"Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumourigenic and tumourigenic cells in vitro","volume":"53","author":"Panayotis, P.; Kozielski, A.J.; Mendoza, J.T.; Early, J.A.; Hinz, H.; Giovanella, B.C.","year":"1993","unstructured":"Panayotis P, Kozielski AJ, Mendoza JT, Early JA, Hinz H, Giovanella BC. Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumourigenic and tumourigenic cells in vitro. Int3tCancer 1993;53:863-71."},{"key":"ref_32","first-page":"168","article-title":"Differential immunohistochemical staining for DNA topoisomerase II-alpha and -beta in human tissues and for DNA topoisomerase II-beta in non-Hodgkin's lymphomas","volume":"10","author":"Bauman, M.E.; Holden, J.A.; Brown, K.A.; Harker, W.G.; Perkins, S.L.","year":"1997","unstructured":"Bauman ME, Holden JA, Brown KA, Harker WG, Perkins SL. Differential immunohistochemical staining for DNA topoisomerase II-alpha and -beta in human tissues and for DNA topoisomerase II-beta in non-Hodgkin's lymphomas. Mod Pathol 1997;10: 168-75.","journal-title":"Mod Pathol"},{"key":"ref_33","first-page":"18982","article-title":"Increased synthesis and degradation of DNA topoisomerase I during the initial phase of human T lymphocyte proliferation","volume":"268","author":"Hwong, C.; Chen, C.; Shang, H.; Hwang, J.","year":"1993","unstructured":"Hwong C, Chen C, Shang H, Hwang J. Increased synthesis and degradation of DNA topoisomerase I during the initial phase of human T lymphocyte proliferation. _7 Biol Che,n 1993;268:18982-6."},{"key":"ref_34","first-page":"509","article-title":"Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity","volume":"74","author":"Mcleod, H.L.; Keith, W.N.","year":"1996","unstructured":"Mcleod HL, Keith WN. Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity. Br7 Cancer 1996;74:509-12."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jcp.1041510306","article-title":"Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from Go to G, phase of the cell cycle and in DNA replication","volume":"151","author":"Bruno, S.; Giaretti, W.; Darzynkiewicz, Z.","year":"1992","unstructured":"Bruno S, Giaretti W, Darzynkiewicz Z. Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from Go to G, phase of the cell cycle and in DNA replication.J Cell Physiol 1992;151:478-86.","journal-title":"J Cell Physiol"},{"article-title":"Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer. Hum Pathol","author":"Lynch, B.J.; Guinee, D.G.; Holden, J.A.","key":"ref_36","unstructured":"Lynch BJ, Guinee DG, Holden JA. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer. Hum Pathol. [In press.]"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0092-8674(87)90518-6","article-title":"DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe","volume":"50","author":"Uemura, T.; Ohkura, H.; Adachi, Y.; Morino, K.; Shiozaki, K.; Yanagida, M.","year":"1987","unstructured":"Uemura T, Ohkura H, Adachi Y, Morino K, Shiozaki K, Yanagida M. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell 1987;50:917-25.","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/MCB.9.1.159","article-title":"DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage","volume":"9","author":"Holm, C.; Stearns, T.; Botstein, D.","year":"1989","unstructured":"Holm C, Stearns T, Botstein D. DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. Mol Cell Biol 1989;9: 159-68.","journal-title":"Mol Cell Biol"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"9531","DOI":"10.1021\/bi00493a006","article-title":"DNA topoisomerase II is required for formation of mitotic chromosomes in chinese hamster ovary cells: studies using the inhibitor 4'demethylepipodophyllotoxin 9-(4, 6-O-thenylidene-3-Dglucopyranoside)","volume":"29","author":"Charron, M.; Hancock, R.","year":"1990","unstructured":"Charron M, Hancock R. DNA topoisomerase II is required for formation of mitotic chromosomes in chinese hamster ovary cells: studies using the inhibitor 4'demethylepipodophyllotoxin 9-(4, 6-O-thenylidene-3-Dglucopyranoside). Biochemistry 1990;29:9531-7.","journal-title":"Biochemistry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/nar\/24.12.2404","article-title":"A novel family of TRF (DNA topoisomerase I-related function) genes required for proper nuclear segregation","volume":"24","author":"Castano, I.B.; Heath-Pagliuso, S.; Sadoff, B.U.; Fitzburgh, D.J.; Christman, M.F.","year":"1996","unstructured":"Castano IB, Heath-Pagliuso S, Sadoff BU, Fitzburgh DJ, Christman MF. A novel family of TRF (DNA topoisomerase I-related function) genes required for proper nuclear segregation. Nucleic Acids Res 1996;24:2404-10.","journal-title":"Nucleic Acids Res"},{"key":"ref_41","first-page":"123743","article-title":"Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA","volume":"4","author":"Muller, M.T.; Pfund, W.P.; Mehta, V.B.; Trask, D.K.","year":"1985","unstructured":"Muller MT, Pfund WP, Mehta VB, Trask DK. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO 1985;4:123743.","journal-title":"EMBO"},{"key":"ref_42","first-page":"1674","article-title":"RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase","volume":"56","author":"Buckwalter, C.A.; Lin, A.H.; Tanizawa, A.; Pommier, Y.G.; Cheng, Y.C.; Kaufmann, S.H.","year":"1996","unstructured":"Buckwalter CA, Lin AH, Tanizawa A, Pommier YG, Cheng YC, Kaufmann SH. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I. Cancer Res 1996;56:1674-81.","journal-title":"I. Cancer Res"},{"key":"ref_43","first-page":"1664","article-title":"Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan","volume":"56","author":"Danks, M.K.; Garrett, K.E.; Marion, R.C.; Whipple, D.O.","year":"1996","unstructured":"Danks MK, Garrett KE, Marion RC, Whipple DO. Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan. Cancer Res 1996; 56:1664-73.","journal-title":"Cancer Res"}],"container-title":["Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/mp.50.5.247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T17:18:10Z","timestamp":1756055890000},"score":1,"resource":{"primary":{"URL":"https:\/\/mp.bmj.com\/lookup\/doi\/10.1136\/mp.50.5.247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[1997,10,1]]},"published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1136\/mp.50.5.247"],"URL":"https:\/\/doi.org\/10.1136\/mp.50.5.247","relation":{},"ISSN":["1366-8714","1472-4154"],"issn-type":[{"type":"print","value":"1366-8714"},{"type":"electronic","value":"1472-4154"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}